Abbott Laboratories (NYSE:ABT) over-valued by 11%
| Website | https://www.abbott.com |
| Sector | Healthcare |
| Industry | Medical Devices |
| Fiscal Year End | Dec 31, 2019 |
| Market Cap | $188,561,457,000 |
| Beta | 0.93292 |
| Average Volume | $5,332,751 |
| Last Dividend | 1.36% |
| Price on Jul 29, 2020 | $108.64 |
| Autochartist™ Valuation | $96.46 |
| Conclusion |
11% over-valued |
| Download Report |
